Fergus Cameron, Australia

Royal Children’s Hospital Department of Endocrinology and Diabetes
Prof. Fergus Cameron BMedSci, MBBS, DipRACOG, FRACP, MD. Fergus Cameron is the Director of the Department of Endocrinology and Diabetes at the Royal Children’s hospital, Melbourne. He is also Head of the Diabetes Research Group at the Murdoch Children’s Research. He has published widely in the medical and lay literature about matters regarding endocrine and diabetes management. His particular interests are the impacts of type 1 diabetes upon central nervous system development and psychosocial aspects of care. He is a past council member of the International Society for Paediatric and Adolescent Diabetes, a past president of the Australasian Paediatric Endocrine Group and is a participant in the Hvidoere Study Group on Childhood Diabetes. He is a Deputy Editor of the journal Pediatric Diabetes.

Presenter of 1 Presentation

 Conference Calendar
PARALLEL SESSION

DEBATE: In the era of remote visits – do we still need A1c measures - PRO

Date
Wed, 02.06.2021
Session Name
0120 - Live Q&A: Parallel Session 01: Future Of Digital Clinics For The Treatment Of Diabetes (ID 14)
Lecture Time
20:51 - 21:15
Presenter
Authors

Abstract

Abstract Body

Debate: In the Era of Remote Visits, Do We Still Need A1c Measures?

Fergus Cameron and Stuart A Weinzimer

Hemoglobin A1c has been the gold standard metric to assess glycemic control in people with type 1 diabetes since the Diabetes Control and Complications Trial, and subsequently has been adopted to other forms of diabetes, as well as for diagnosing diabetes. However, the rapidly increasing use of continuous glucose monitoring (CGM) has enabled clinicians to assess metrics of glycemia more directly; and with the growing popularity of telemedicine, driven most urgently in the past year by the COVID pandemic, the role of A1c as a clinically important measure has been questioned. In this debate, we will discuss the relative merits and limitations of A1c and CGM, and whether continuing use of A1c measures in clinical care is still warranted.

Hide